We are live on ! Find out more
COYA icon

Coya Therapeutics
COYA

7 hedge funds and large institutions have $4.37M invested in Coya Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding

Funds holding: 4 → 7 (+3)

0.2% less ownership

Funds ownership: 11.27% → 11.07% (-0.2%)

15% less capital invested

Capital invested by funds: $5.16M → $4.37M (-$788K)

Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$33.8K
2
UBS Group
UBS Group
Switzerland
+$7.13K
3
TWM
Tradition Wealth Management
Minnesota
+$3.71K
4
GC
Greenlight Capital
New York
+$887
5
Wells Fargo
Wells Fargo
California
+$96

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$2.22M – – –
GC
2
Greenlight Capital
New York
$1.56M +$887 +203 +0.1%
WVP
3
Worth Venture Partners
New Jersey
$543K – – –
BlackRock
4
BlackRock
New York
$30.7K +$33.8K +7,727 New
UBS Group
5
UBS Group
Switzerland
$11.3K +$7.13K +1,631 +134%
TWM
6
Tradition Wealth Management
Minnesota
$3K +$3.71K +849 New
Wells Fargo
7
Wells Fargo
California
$87 +$96 +22 New

COYA Hedge Fund Activity: Q1 2023 in Review

7 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2023, worth a combined $4.37M — down 15% from $5.16M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new COYA positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $33.8K.

  • 7 institutional investors held Coya Therapeutics (COYA) as of Q1 2023, up from 4 in Q4 2022.
  • Funds reported $4.37M of Coya Therapeutics stock for Q1 2023, down 15% quarter-over-quarter.
  • 3 funds opened new Coya Therapeutics positions in Q1 2023 and 0 closed out, a net change of +3 holders.
  • The largest Coya Therapeutics buyer in Q1 2023 was BlackRock, an estimated $33.8K added.

Based on aggregated 13F filings for Q1 2023.